Riesgos y consecuencias de los pacientes diagnosticados con neumonía al adquirir el virus SARS-CoV-2
The coronavirus disease (COVID-19) pandemic is currently a challenge around the world. In many countries so far, there has been a crisis in the health system as a result of the ravages caused by the pandemic. Treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV-2 infecti...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
2021
|
| Subjects: | |
| Online Access: | https://dialnet.unirioja.es/servlet/oaiart?codigo=7941094 |
| Source: | RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 5, Nº. 1, 2021, pags. 207-216 |
| Tags: |
Add Tag
No Tags: Be the first to tag this record
|
| Summary: |
The coronavirus disease (COVID-19) pandemic is currently a challenge around the world. In many countries so far, there has been a crisis in the health system as a result of the ravages caused by the pandemic. Treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV-2 infections, should continue to be based on evidence-based NAC guidelines during the pandemic; however, the specific adjustments of COVID-19 have been helpful. Treatment of patients with chronic lung diseases must be adapted during the pandemic to ensure patient stability, this is because SARSCoV-2 infections present specific and different individual phenotypes. In that sense, the application of a personalized approach would benefit the optimization of therapies and the improvement of the results. The clinical spectrum of SARS-CoV-2 infection is wide, from asymptomatic infection to flu-like illness (sometimes with digestive disorders) and viral pneumonia.
Patients with pneumonia may have only a minor appearance with nearly normal chest radiographs, but have the potential to develop acute respiratory failure with rapidly progressing severe hypoxemia. The following research development presents the most marked risks and consequences in patients with pneumonia who have acquired the SARS-CoV-2 virus |
|---|